SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-24-000068
Filing Date
2024-08-01
Accepted
2024-08-01 07:33:41
Documents
88
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz-20240630.htm   iXBRL 10-Q 1661546
2 OFFER LETTER jazzq22024ex102.htm EX-10.2 21262
3 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22024ex311.htm EX-31.1 10264
4 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22024ex312.htm EX-31.2 10332
5 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq22024ex321.htm EX-32.1 7025
  Complete submission text file 0001232524-24-000068.txt   8982766

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20240630.xsd EX-101.SCH 55443
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20240630_cal.xml EX-101.CAL 101330
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20240630_def.xml EX-101.DEF 309672
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20240630_lab.xml EX-101.LAB 725191
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20240630_pre.xml EX-101.PRE 523298
91 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20240630_htm.xml XML 1423521
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 241164301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)